Establishment of a real-time PCR for quantifying transforming growth factor beta1 in blood of hepatocellular carcinoma patients

Journal of Medical Colleges of PLA

Volumn 23, Issue 4, 2008, Pages 228-236

  Peng, Qi ^a   Chunfang, Gao ^a   Meng, Fang ^a   Qiang, Ji ^a   Yunpeng, Zhao ^a   Yan, Liu ^a   Xiaojuan, Sun ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Early diagnosis; Hepatocellular carcinoma; Messenger RNA; Molecular marker; Quantitative PCR; Transforming growth factor beta1

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALPHA FETOPROTEIN; ALPHA LEVO FUCOSIDASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; GAMMA GLUTAMYLTRANSFERASE; MESSENGER RNA; PREALBUMIN; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGE; AGED; ARTICLE; BLOOD ANALYSIS; CANCER GRADING; CANCER SIZE; CONTROLLED STUDY; EARLY DIAGNOSIS; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROCESS OPTIMIZATION; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; THROMBOCYTE COUNT; VIRUS LOAD;

EID: 77950133759     PISSN: 10001948     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1000-1948(08)60047-7     Document Type: Article

References (26)

1. Sun K, Wang L, Zhang Y Dendritic cell as therapeutic vaccines against tumors and its role in therapy for hepatocellular carcinoma. Cell Mol Immunol 2006, 3(3):197-203.
2. Bosch FX, Ribes J, Cléries R, et al. Epidemiology of hepatocellular carcinoma. Clin Liver Dis 2005, 9(2):191-211.
3. Chen XP, Qiu FZ, Wu ZD, et al. Long-term outcome of resection of large hepatocellular carcinoma. Br J Surg 2006, 93(5):600-606.
4. Shi M, Zhang CQ, Zhang YQ, et al. Micrometastases of solitary hepatocellular carcinoma and appropriate resection margin. World J Surg 2004, 28(4):376-381.
5. Gressner AM, Weiskirchen R, Breitkopf K, et al. Roles of TGF-β in hepatic fibrosis. Front Biosci 2002, 7:D793-D807.
6. Sánchez-Capelo A Dual role for TGF-beta1 in apoptosis. Cytokine Growth Factor Rev 2005, 16(1):15-34.
7. Ito N, Kawata S, Tamura S, et al. Elevated levels of transforming growth factor beta messenger RNA and its polypeptide in human hepatocellular carcinoma. Cancer Res 1991, 51(15):4080-4083.
8. Shirai Y, Kawata S, Tamura S, et al. Plasma transforming growth factor-beta 1 in patients with hepatocellular carcinoma. Comparison with chronic liver diseases. Cancer 1994, 73(9):2275-2279.
9. Abou-Shady M, Baer HU, Friess H, et al. Transforming growth factor betas and their signaling receptors in human hepatocellular carcinoma. Am J Surg 1999, 177(3):209-215.
10. Factor VM, Kao CY, Santoni-Rugiu E, et al. Constitutive expression of mature transforming growth factor beta1 in the liver accelerates hepatocarcinogenesis in transgenic mice. Cancer Res 1997, 57(11):2089-2095.
11. Song BC, Chung YH, Yang SH, et al. Expression of transforming growth factor-β1 in hepatocellular carcinoma and surrounding liver. Kor J Gastroenterol 1999, 34:774-783.
12. Kim HG, Chung YH, Song BC, et al. Expression of transforming growth factor beta-1 in chronic hepatitis and hepatocellular carcinoma associated with hepatitis C virus infection. Korean J Intern Med 2000, 15(3):165-170.
13. Matsuzaki K, Date M, Furukawa F, et al. Autocrine stimulatory mechanism by transforming growth factor beta in human hepatocellular carcinoma. Cancer Res 2000, 60(5):1394-1402.
14. Ji GZ, Zhao ZQ, Miu L, et al. Studies on expressions of TGF-β1mRNA and protein in patients with hepatocellular carcinoma. Jiangsu Yi Yao Za Zhi 2003, 29(7):485-487. (In Chinese).
15. Grizzi F, Franceschini B, Hamrick C, et al. Usefulness of cancer-testis antigens as biomarkers for the diagnosis and treatment of hepatocellular carcinoma. J Transl Med 2007, 5:3.
16. Yao DF, Dong ZZ, Yao M Specific molecular markers in hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 2007, 6(3):241-247.
17. Zhou L, Liu J, Luo F Serum tumor markers for detection of hepatocellular carcinoma. World J Gastroenterol 2006, 12(8):1175-1181.
18. Lopez JB Recent developments in the first detection of hepatocellular carcinoma. Clin Biochem Rev 2005, 26(3):65-79.
19. Mann CD, Neal CP, Garcea G, et al. Prognostic molecular markers in hepatocellular carcinoma: a systematic review. Eur J Cancer 2007, 43(6):979-992.
20. Smith B, Selby P, Southgate J, et al. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 1991, 338(8777):1227-1229.
21. Matsumura M, Niwa Y, Kato N, et al. Detection of alpha-fetoprotein mRNA, an indicator of hematogenous spreading hepatocellular carcinoma, in the circulation: a possible predictor of metastatic hepatocellular carcinoma. Hepatology 1994, 20(6):1418-1425.
22. Hillaire S, Barbu V, Boucher E, et al. Albumin messenger RNA as a marker of circulating hepatocytes in hepatocellular carcinoma. Gastroenterology 1994, 106(1):239-242.
23. Schulte-Hermann R, Bursch W, Löw-Baselli A, et al. Apoptosis in the liver and its role in hepatocarcinogenesis. Cell Biol Toxicol 1997, 13(4-5):339-348.
24. Osada T, Sakamoto M, Ino Y, et al. E-cadherin is involved in the intrahepatic metastasis of hepatocellular carcinoma. Hepatology 1996, 24(6):1460-1467.
25. Naor D, Sionov RV, Ish-Shalom D CD44: structure, function, and association with the malignant process. Adv Cancer Res 1997, 71:241-319.
26. Tanaka Y, Mimori K, Shiraishi T, et al. Alpha6 integrin expression in esophageal carcinoma. Int J Oncol. 2000, 16(4):725-729.